Edesa Biotech Inc (EDSA)
4.632
+0.08
(+1.70%)
USD |
NASDAQ |
May 03, 16:00
4.53
-0.10
(-2.21%)
After-Hours: 20:00
Edesa Biotech Cash from Operations (TTM): -6.252M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -6.252M |
September 30, 2023 | -6.636M |
June 30, 2023 | -10.80M |
March 31, 2023 | -12.02M |
December 31, 2022 | -10.86M |
September 30, 2022 | -12.28M |
June 30, 2022 | -7.006M |
March 31, 2022 | -7.099M |
December 31, 2021 | -13.86M |
September 30, 2021 | -13.66M |
June 30, 2021 | -14.98M |
March 31, 2021 | -13.22M |
December 31, 2020 | -7.207M |
September 30, 2020 | -4.986M |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | -4.617M |
December 31, 2018 | -4.780M |
September 30, 2018 | -4.616M |
June 30, 2018 | -4.761M |
March 31, 2018 | -4.591M |
December 31, 2017 | -4.479M |
Date | Value |
---|---|
September 30, 2017 | -4.700M |
June 30, 2017 | -4.774M |
March 31, 2017 | -4.899M |
December 31, 2016 | -4.696M |
September 30, 2016 | -4.506M |
June 30, 2016 | -4.229M |
March 31, 2016 | -4.078M |
December 31, 2015 | -4.301M |
September 30, 2015 | -4.412M |
June 30, 2015 | -4.314M |
March 31, 2015 | -4.432M |
December 31, 2014 | -4.366M |
August 31, 2014 | -4.267M |
May 31, 2014 | -4.009M |
February 28, 2014 | -3.701M |
November 30, 2013 | -3.260M |
August 31, 2013 | -2.796M |
May 31, 2013 | -3.162M |
February 28, 2013 | -3.440M |
November 30, 2012 | -3.779M |
August 31, 2012 | -3.948M |
May 31, 2012 | -3.932M |
February 29, 2012 | -3.918M |
November 30, 2011 | -3.429M |
August 31, 2011 | -2.618M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-14.98M
Minimum
Jun 2021
-4.986M
Maximum
Sep 2020
-10.06M
Average
-10.83M
Median
Cash from Operations (TTM) Benchmarks
Acasti Pharma Inc | -13.57M |
Aurinia Pharmaceuticals Inc | -33.46M |
Lexaria Bioscience Corp | -5.209M |
Xenon Pharmaceuticals Inc | -145.33M |
ESSA Pharma Inc | -22.19M |